Umbilical Cord Blood Transplantation From Unrelated Donors
University of Rochester
30 participants
Jun 1, 2015
OBSERVATIONAL
Conditions
Summary
This study is being done to determine how long it takes for the engraftment (recovery of blood cell counts) of umbilical cord stem cells and also how often engraftment of umbilical cord stem cells transplanted from an unrelated donor fails. Another purpose will be to document the rate of disease-free survival and the rate of relapse (a return of your disease or syndrome) as well as the incidence and severity of graft versus host disease (GvHD) following cord blood stem cell transplantation. GvHD is a complication of stem cell transplants in which white blood cells from the transplanted tissue (graft) attack the transplant recipient's body (host).
Eligibility
Plain Language Summary
Simplified for easier understanding
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Total Body Irradiation 1200 cGy in 8 fractions
Total Body Irradiation 200 cGy in one fraction
50 mg/kg or 60 mg/kg
50 mg/kg or 60 mg/kg plus 10% loading dose
Intravenous infusion of cord blood stem cells
0.8 mg/kg x 16 doses
30 mg/m2/day x 5 or 40 mg/m2/day x 5
140 mg/m2
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT03016806